P

Inventor

VISCOMI GIUSEPPE CLAUDIO

IT38 patents
⚠️ This page may combine multiple inventors who share the name “VISCOMI GIUSEPPE CLAUDIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALFA WASSERMANN SPA

12 patents
US7906542B2Mar 15, 2011

Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

ALFA WASSERMANN SPA40 citations96
US9271968B2Mar 1, 2016

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

ALFA WASSERMANN SPA14 citations92
US8853231B2Oct 7, 2014

Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

ALFA WASSERMANN SPA15 citations92
US8835452B2Sep 16, 2014

Polymorphic forms α, β and γ of rifaximin

ALFA WASSERMANN SPA15 citations92
US8741904B2Jun 3, 2014

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

ALFA WASSERMANN SPA20 citations92
US7902206B2Mar 8, 2011

Polymorphic forms α, β and γ of rifaximin

ALFA WASSERMANN SPA28 citations92
US7923553B2Apr 12, 2011

Processes for the production of polymorphic forms of rifaximin

ALFA WASSERMANN SPA18 citations84
US9938298B2Apr 10, 2018

Solvated crystal form of rifaximin, production, compositions and uses thereof

ALFA WASSERMANN SPA2 citations67
US9452157B2Sep 27, 2016

Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof

ALFA WASSERMANN SPA5 citations66
US6866782B2Mar 15, 2005

Process for the purification of pharmacologically active proteins through cationic exchange chromatography

ALFA WASSERMANN SPA11 citations66
US9498442B2Nov 22, 2016

Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

ALFA WASSERMANN SPA1 citations50
US10258657B2Apr 16, 2019

Therapeutic and nutritional compositions for functional gastrointestinal disorders

ALFA WASSERMANN SPA0 citations40

VISCOMI GIUSEPPE CLAUDIO

11 patents
US8193196B2Jun 5, 2012

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

VISCOMI GIUSEPPE CLAUDIO40 citations96
US8173801B2May 8, 2012

Processes for the production of polymorphic forms of rifaximin

VISCOMI GIUSEPPE CLAUDIO14 citations92
US8158781B2Apr 17, 2012

Polymorphic forms α, β and γ of rifaximin

VISCOMI GIUSEPPE CLAUDIO27 citations92
US8158644B2Apr 17, 2012

Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

VISCOMI GIUSEPPE CLAUDIO26 citations92
US8518949B2Aug 27, 2013

Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

VISCOMI GIUSEPPE CLAUDIO25 citations91
US8404704B2Mar 26, 2013

Use of polymorphic forms of rifaximin for medical preparations

VISCOMI GIUSEPPE CLAUDIO12 citations90
US8568782B2Oct 29, 2013

Gastroresistant pharmaceutical formulations containing rifaximin

VISCOMI GIUSEPPE CLAUDIO24 citations88
US8748447B2Jun 10, 2014

Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

VISCOMI GIUSEPPE CLAUDIO5 citations81
US8318763B2Nov 27, 2012

Rifamycin derivatives

VISCOMI GIUSEPPE CLAUDIO5 citations69
US10258610B2Apr 16, 2019

Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections

VISCOMI GIUSEPPE CLAUDIO0 citations43
US8987231B2Mar 24, 2015

Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved

VISCOMI GIUSEPPE CLAUDIO1 citations39

ALFASIGMA SPA

6 patents

SALIX PHARMACEUTICALS LTD

3 patents

MAFFEI PAOLA

2 patents

GUSHURST KAREN S

2 patents

SALIX PHARMACEUTICALS INC

1 patent

THERAVANCE BIOPHARMA R&D IP LLC

1 patent